The duration of pretreatment with ticlopidine prior to stenting is associated with the risk of procedure-related non–Q-wave myocardial infarctions
about
The thienopyridinesOral antiplatelet therapy and percutaneous coronary interventionAspirin and platelet adenosine diphosphate receptor antagonists in acute coronary syndromes and percutaneous coronary intervention: role in therapy and strategies to overcome resistance.Bisphosphonates as anti-inflammatory agents in ankylosing spondylitis and spondylarthropathies.Peri-procedural myocardial injury: 2005 update.
P2860
The duration of pretreatment with ticlopidine prior to stenting is associated with the risk of procedure-related non–Q-wave myocardial infarctions
description
im November 1998 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 November 1998
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 1998
@uk
name
The duration of pretreatment w ...... –Q-wave myocardial infarctions
@en
The duration of pretreatment w ...... –Q-wave myocardial infarctions
@nl
type
label
The duration of pretreatment w ...... –Q-wave myocardial infarctions
@en
The duration of pretreatment w ...... –Q-wave myocardial infarctions
@nl
prefLabel
The duration of pretreatment w ...... –Q-wave myocardial infarctions
@en
The duration of pretreatment w ...... –Q-wave myocardial infarctions
@nl
P2093
P50
P1476
The duration of pretreatment w ...... -Q-wave myocardial infarctions
@en
P2093
A M Lincoff
D J Moliterno
S R Steinhubl
P304
P356
10.1016/S0735-1097(98)00376-3
P407
P577
1998-11-01T00:00:00Z